Clinical Scorecard: Depression and Anxiety Symptoms in Adults With Type 1 Diabetes
At a Glance
Category
Detail
Condition
Clinical topic addressed by the source article: Depression, anxiety symptoms may be common in T1D
Key Mechanisms
The study measured depressive and generalized anxiety symptoms using the PHQ-8 and GAD-7; it did not confirm clinical diagnoses.
Target Population
Population described in the source article.
Care Setting
Population-based analysis of 2019 and 2022 National Health Interview Survey data.
Key Highlights
In 2019 and 2022 National Health Interview Survey data, 17% of adults with type 1 diabetes reported moderate or severe depressive symptoms, compared with 12% with type 2 diabetes and 7% without diabetes.
Moderate or severe generalized anxiety symptoms were reported by 16% of adults with type 1 diabetes, compared with 9% with type 2 diabetes and 6% without diabetes.
Severe depressive symptoms were reported by 10% of adults with type 1 diabetes and severe generalized anxiety symptoms by 8%.
Symptom prevalence varied by age, sex, and educational attainment; subgroup estimates were limited by the small type 1 diabetes sample. The survey did not assess diabetes-specific psychosocial burdens, which may overlap with depressive and anxiety symptoms.
Symptoms were assessed over the preceding 2 weeks and were not confirmed through clinical interviews.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
The article reports the American Diabetes Association’s 2026 recommendation for annual depression and anxiety screening using validated instruments.
Risks
Patient & Prescribing Data
The analysis included 58,106 US adults: 326 classified as having type 1 diabetes, 5,802 as having type 2 diabetes, and the remainder without diabetes.
The article reports screening recommendations and symptom prevalence; it provides no medication or other treatment regimen.
Clinical Best Practices
The article reports the ADA’s recommendation for annual depression and anxiety screening using validated instruments.
The study used questionnaire symptom scores, not clinical interviews, to confirm diagnoses.
The authors note possible diabetes-subtype misclassification, limited precision of type 1 diabetes subgroup estimates, and unmeasured diabetes-specific psychosocial burdens.
